PRELIMINARY CLINICAL RESULTS WITH A NEW ANTITUMOR AGENT RO 4-6467 (NSC-77213).
D000970:Antineoplastic Agents; D001855:Bone Marrow Diseases; D004802:Eosinophilia; D005853:Geriatrics; D006461:Hemolysis; D006689:Hodgkin Disease; D006834:Hydrazines; D007938:Leukemia; D007945:Leukemia, Lymphoid; D008218:Lymphocytosis; D008223:Lymphoma; D008224:Lymphoma, Follicular; D008228:Lymphoma, Non-Hodgkin; D009325:Nausea; D009369:Neoplasms / Q000628:therapy*; D013902:Radiography, Thoracic; D014116:Toxicology; D014839:Vomiting
D000970:Antineoplastic Agents; D006834:Hydrazines
ANTINEOPLASTIC AGENTS; BONE MARROW DISEASES; EOSINOPHILIA; GERIATRICS; HEMOLYSIS; HODGKIN'S DISEASE; HYDRAZINES; LEUKEMIA, LYMPHOCYTIC; LYMPHOCYTOSIS; LYMPHOMA, GIANT FOLLICULAR; LYMPHOSARCOMA; NAUSEA; NEOPLASM THERAPY; THORACIC RADIOGRAPHY; TOXICOLOGIC REPORT; VOMITING